CMPX
Compass Therapeutics Inc.
NASDAQ: CMPX · HEALTHCARE · BIOTECHNOLOGY
$1.77
+5.99% today
Updated 2026-04-30
Market cap
$300.75M
P/E ratio
—
P/S ratio
269.28x
EPS (TTM)
$-0.42
Dividend yield
—
52W range
$2 – $7
Volume
6.9M
Compass Therapeutics Inc. (CMPX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-41.30%
ROA
-25.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-38.29M | — | — | — |
| 2019 | $0.00 | $-34.74M | — | — | — |
| 2020 | $0.00 | $-29.50M | — | — | — |
| 2021 | $0.00 | $-82.18M | — | — | — |
| 2022 | $0.00 | $-39.23M | — | — | — |
| 2023 | $0.00 | $-42.49M | — | — | — |
| 2024 | $850000.00 | $-49.38M | 100.00% | -6,661.76% | -5,808.82% |
| 2025 | $0.00 | $-66.49M | — | — | — |